🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary aim of this study is to assess the safety and tolerability of o...
Status
Completed
Location
Altman Clinical and Translational Research Institute
Start Date
2021-05-01
Trial ID
NCT04661514
Treatments Being Tested
The purpose of the present study is to evaluate the feasibility, initial si...
Status
Withdrawn
Location
University of Alabama at Birmingham
Start Date
2023-08-15
Trial ID
NCT05227742
Treatments Being Tested
This pilot clinical trial will study psilocybin-assisted therapy for adults...
Status
Not Yet Recruiting
Location
Arthur Child Comprehensive Cancer Centre
Start Date
2026-10-30
Trial ID
NCT07791901
The purpose of this research study is to investigate whether a single admin...
Status
Not Yet Recruiting
Location
Connecticut Mental Health Center
Start Date
2026-10
Trial ID
NCT07306364
Treatments Being Tested
This is a multi-site, double-blind, randomized clinical trial of the 5-HT2A...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2023-11-01
Trial ID
NCT05452772
Treatments Being Tested
The principal investigator for this study plans to build upon the psilocybi...
Status
Recruiting
Location
Baylor College of Medicine
Start Date
2025-01-30
Trial ID
NCT06888128
Treatments Being Tested
Approximately 240 eligible adult participants (≥18 years old) who meet Diag...
Status
Active Not Recruiting
Location
University of Alabama Clinical Research Unit
Start Date
2024-03-13
Trial ID
NCT06308653
Treatments Being Tested
Psilocybin, a serotonin receptor agonist in the brain, significantly and qu...
Status
Not Yet Recruiting
Location
GHU Paris Psychiatrie and Neurosciences
Start Date
2025-10-08
Trial ID
NCT07210112
Treatments Being Tested
The study aims to investigate the safety and efficacy of oral psilocybin ad...
Status
Completed
Location
Charité Berlin, Campus Mitte, Department of Psychiatry and Psychotherapy
Start Date
2021-06-10
Trial ID
NCT04670081
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and pote...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-01
Trial ID
NCT05562973
Treatments Being Tested